Ontosight.ai vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-18
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionOntosight.aiIsomorphic Labs
PricingFreemium (Pro/Team plans available)Contact-based (enterprise partnerships only)
Target UsersIndividual researchers, students, medical writersLarge pharma companies, research institutions
Core CapabilitiesConversational Q&A, summarization, manuscript drafting citing PubMed, DrugBank, etc.Predictive/generative AI for protein-ligand interactions, novel molecule design
Integration & DeliveryWeb platform with PubMed, DrugBank, ClinicalTrials.gov integrationsPharma partnership model, no standalone API or product
Best ForBiomedical literature research, clinical guideline lookupsLarge-scale drug discovery lead optimization

If you're an individual researcher needing a life sciences research assistant with citations, Ontosight.ai's freemium model and integrations are immediately usable. If you're a large pharma company seeking to accelerate drug discovery at scale, Isomorphic Labs' AI-first platform, backed by AlphaFold and major partnerships, is the clear choice—but it requires a deep collaboration commitment.

Ontosight.ai
Ontosight.ai

Conversational AI research assistant for life sciences that returns evidence-backed answers with citations from 75M+ scientific records.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs uses AI drug discovery models to design novel molecules and predict how candidate drugs will perform.

Visit Website
Pricing
Freemium
Contact Sales
Plans
$0/mo
$29/mo
$99/mo
—
Popularity
6 views
7.5k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
—
Categories
🔬 Research & Education❓ Document Q&A & Summarizing🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
Conversational research Q&A returning evidence-backed answers with citations
Smart literature synthesis that compares studies and surfaces gaps and trends
Narrative-to-systematic literature review support
Chat with uploaded PDFs to ask, extract and summarise papers
Paper and abstract summarisation
Abstract generation and title crafting
Thesis refinement and essay expansion
Biomedical knowledge graph as the retrieval foundation
Clinical guideline lookups
Clinical trial search across a claimed 1M+ trials
Patent search across a claimed 12M+ patents
Role-specific views for clinicians and for researchers
Drill-down references on every generated answer
Browser-based web access, no install required
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Built on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Announced a new path to making medicines with AI
Series B announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Founded by Demis Hassabis, who serves as CEO

What real users say: Ontosight.ai vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Ontosight.ai

21 mentions across 3 sources · 30% positive — critical (averaged across 3 sources)

Hacker News, YouTube, Product Hunt

What users praise

  • • Finds relevant, cited literature for biomedical queries.
  • • Tailored to life sciences, giving it an edge over general-purpose AI.
  • • Integration with PubMed, DrugBank, and ClinicalTrials.gov is valuable.
  • • Multi-turn conversations let you dig deeper into a topic.

What frustrates them

  • • Source listings lack inline pointers—users can't verify claims easily.
  • • Only available via web; no mobile or desktop app for on-the-go.
  • • Team features locked behind Pro/Team, pushing costs up fast.
  • • No independent comparison against Perplexity or Elicit yet.

Researched Sep 1, 2026

Isomorphic Labs

No verifiable community signal. We scanned public discussion on Oct 14, 2026 and found posts matching the name “Isomorphic Labs”, but could not establish that they are about this product rather than something else sharing its name. Rather than publish a score built on the wrong subject, we publish none.

Who should pick which

  • Biomedical PhD student
    Pick: Ontosight.ai

    Needs quick summarization and citation from PubMed; Ontosight.ai's freemium plan and natural language queries fit perfectly.

  • Large pharma R&D director
    Pick: Isomorphic Labs

    Aims to accelerate lead optimization with AI; Isomorphic Labs' partnership model and AlphaFold integration provide cutting-edge predictive power.

  • Medical writer reporting on clinical trials
    Pick: Ontosight.ai

    Can use Ontosight.ai to draft manuscripts with cited sources from ClinicalTrials.gov and PubMed.

  • Small biotech exploring drug repurposing
    Pick: Ontosight.ai

    Ontosight.ai can quickly retrieve drug interaction data; Isomorphic Labs' partnership model is too heavy for early-stage exploration.

  • Academic research group studying protein structures
    Pick: Isomorphic Labs

    If partnered with a pharma company, they could access Isomorphic Labs' AlphaFold-based predictions; otherwise, non-partnered academics should use public AlphaFold.

Frequently Asked Questions

Ontosight.ai vs Isomorphic Labs: which should you choose?

If you're an individual researcher needing a life sciences research assistant with citations, Ontosight.ai's freemium model and integrations are immediately usable. If you're a large pharma company seeking to accelerate drug discovery at scale, Isomorphic Labs' AI-first platform, backed by AlphaFold and major partnerships, is the clear choice—but it requires a deep collaboration commitment.

Can I use Ontosight.ai for drug discovery?

It aids literature review and data retrieval, but not predictive molecule design—that's Isomorphic Labs' domain.

Is Isomorphic Labs available as a SaaS product?

No. It operates through pharma collaborations only—no standalone API or web interface.

Which tool is better for a student?

Ontosight.ai with its freemium model and PubMed integration is ideal.

Does Isomorphic Labs have recent funding?

Yes, a $600M external round in 2025 and a Series B in February 2026.

Can Ontosight.ai handle chemical structure queries?

It references databases like DrugBank but does not generate novel molecules.

What partnerships does Isomorphic Labs have?

It collaborates with Novartis and Johnson & Johnson (announced Jan 2026).

Does Ontosight.ai support team collaboration?

Yes, through its Pro/Team plans with shared workspaces.

Which tool is more cost-effective for a startup?

Ontosight.ai's freemium model is affordable; Isomorphic Labs requires large-scale investment.

More Ontosight.ai or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026